Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ionescu

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Depression and Anxiety|January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|November 16, 2022
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine StudyAnna Feeney, Bettina B Hoeppner, Marlene P Freeman, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
Journal of Affective Disorders|October 5, 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trialDawn F Ionescu, Kate H Bentley, Matthias Eikermann, et al.
Psychopharmacology|January 6, 2016
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depressionErica M Richards, Daniel C Mathews, David A Luckenbaugh, et al.
Molecular Psychiatry|October 5, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Molecular Psychiatry|January 9, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Depression and Anxiety|January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|November 16, 2022
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine StudyAnna Feeney, Bettina B Hoeppner, Marlene P Freeman, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
Journal of Affective Disorders|October 5, 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trialDawn F Ionescu, Kate H Bentley, Matthias Eikermann, et al.
Psychopharmacology|January 6, 2016
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depressionErica M Richards, Daniel C Mathews, David A Luckenbaugh, et al.
Molecular Psychiatry|October 5, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Molecular Psychiatry|January 9, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Pageof 8